Get startedLog in
    Picture of Candel Therapeutics logo

    CADL — Candel Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareMid CapNeutral
    All News

    Brief: Candel Therapeutics Receives FDA Orphan Drug Designation For CAN-2409 For Treatment Of Pancreatic Cancer

    Picture of Candel Therapeutics logoCandel Therapeutics
    11/04/2024 15:16
    April 11 (Reuters) - Candel Therapeutics Inc  CADL.O :
    * CANDEL THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION
FOR
CAN-2409 FOR THE TREATMENT OF PANCREATIC CANCER

Source text for Eikon:  ID:nGNX66Yf2J 
Further company coverage:  CADL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Candel Therapeutics

    See all news